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University of Exeter Medical School, University of Exeter, Exeter, UKA B S T R A C TBackground: Condition-speciﬁc measures are frequently used to
assess the health-related quality of life of people with multiple
sclerosis (MS). Such measures are unsuitable for use in economic
evaluations that require estimates of cost per quality-adjusted life-
year because they are not based on preferences. Objectives: To report
the estimation of a preference-based single index for an eight-
dimensional instrument for MS, the Multiple Sclerosis Impact Scale
– Eight Dimensions (MSIS-8D), derived from an MS-speciﬁc measure of
health-related quality of life, the 29-item Multiple Sclerosis Impact
Scale (MSIS-29). Methods: We elicited preferences for a sample of
MSIS-8D states (n ¼ 169) from a sample (n ¼ 1702) of the UK general
population. Preferences were elicited using the time trade-off techni-
que via an Internet-based survey. We ﬁtted regression models to these
data to estimate values for all health states described by the MSIS-8D.
Estimated values were assessed against MSIS-29 scores and
values derived from generic preference-based measures in a large,
representative sample of people with MS. Results: Participantsee front matter Copyright & 2015, International S
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ter EX12LU, UK.reported that the time trade-off questions were easy to understand.
Observed health state values ranged from 0.08 to 0.89. The best-
performing model was a main effects, random effects model (mean
absolute error ¼ 0.04). Validation analyses support the performance of
the MSIS-8D index: it correlated more strongly than did generic
measures with MSIS-29 scores, and it discriminated effectively between
subgroups of people with MS. Conclusions: The MSIS-8D enables
health state values to be estimated from the MSIS-29, adding to the
methods available to assess health outcomes and to estimate quality-
adjusted life-years for MS for use in health technology assessment and
decision-making contexts.
Keywords: multiple sclerosis, preference-based measures, quality-
adjusted life-years.
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The cost-effectiveness of health care interventions is often
assessed using cost-utility analysis, in which health outcomes
are measured using quality-adjusted life-years (QALYs). The
QALY incorporates the effects of treatment on longevity and
quality of life by weighting each life-year according to its quality,
on a scale from 1 (full health) to 0 (equivalent to being dead). A
common method of obtaining QALY weights is to use an existing
preference-based measure (PBM) of health-related quality of life
(HRQoL), which provides a tariff of QALY weights for a large
number of health states. The most frequently used PBMs are
generic; that is, they are considered applicable for all health
conditions [1]. These include the EuroQol ﬁve-dimensional ques-
tionnaire (EQ-5D) [2], the six-dimensional health state short form
(derived from short form 36 health survey) (SF-6D) [3], or the
Health Utilities Index (HUI) [4]. The appropriateness of these
measures has been questioned for some health conditions,
including multiple sclerosis (MS) [5].MS is a progressive neurological condition that affects the
central nervous system, causing a wide range of symptoms,
which vary between individuals and within the same individual
over time [6]. The disease may initially follow a relapsing-
remitting pattern, eventually becoming progressive, or may be
progressive from onset. Levels of disability increase as the
disease progresses [7]. The empirical evidence on the suitability
of generic PBMs (GPBMs) for use in MS is equivocal. A number of
studies have raised concerns about the content validity [6,8–10] or
the sensitivity [6,11–13] of GPBMs in the context of MS. A recent
systematic review [5] reports an assessment of the psychometric
properties of six GPBMs (EQ-5D, HUI2, HUI3, SF-6D, the Assess-
ment of Quality of Life instrument, and the Quality of Well Being
Scale) when applied to MS, ﬁnding that each measure has
particular strengths and weaknesses. The HUI3 performed best
in terms of its psychometric properties, but it is regarded as a
measure of impairment rather than HRQoL. The content validity
of the EQ-5D and the SF-6D was considered to be compromised
because of the omission of domains of HRQoL that are importantociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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Table 1 – The MSIS-8D classiﬁcation system.
Physical subscale (includes all physical and social dimensions)
Dimension MSIS-29 item Response levels
Physical In the past two weeks, how much has your MS limited your ability to do physically demanding tasks? 1 2 3 4
In the past two weeks, how much have you been bothered by:
Social Limitations in your social and leisure activities at home? 1 2 3 4
Mobility Being stuck at home more than you would like to be? 1 2 3 4
Daily activities Having to cut down the amount of time you spent on work or other daily activities? 1 2 3 4
Psychological subscale (includes all psychological and other nonphysical dimensions)
Dimension MSIS-29 item Response levels
In the past two weeks, how much have you been bothered by:
Fatigue Feeling mentally fatigued? 1 2 3 4
Emotion Feeling irritable, impatient, or short-tempered? 1 2 3 4
Cognition Problems concentrating? 1 2 3 4
Depression Feeling depressed? 1 2 3 4
Note. Response levels: 1 ¼ not at all; 2 ¼ a little; 3 ¼ moderately; 4 ¼ extremely.
MSIS-8D, Multiple Sclerosis Impact Scale – Eight Dimensions; MSIS-29, 29-item Multiple Sclerosis Impact Scale.
V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 1 0 2 5 – 1 0 3 61026in MS, speciﬁcally fatigue (EQ-5D), mobility (SF-6D), and cognition
(both measures). The discriminative validity of the EQ-5D and the
SF-6D was assessed as limited across the full range of condition
severity for MS, and both measures exhibited ﬂoor and ceiling
effects. Assessment of the other instruments was limited because
of a lack of data. The review concludes that the development of
an MS-speciﬁc PBM is a possible area for future research. Such a
PBM could be used in the absence of GPBM data, or as a supple-
ment to GPBM data to provide more detailed information about
the effect of treatments on the HRQoL of people with MS.
A range of condition-speciﬁc instruments are available to
measure the health status of people with MS, and they are
regarded as more appropriate than generic measures for MS
because of their focus on the most relevant aspects of HRQoL
[11]. Such measures are not preference-based and do not provide
the quality weights required for the calculation of QALYs. They
can, however, be used as the basis of a condition-speciﬁc prefer-
ence-based measure (CSPBM), and this has become a common
approach over recent years, across a range of conditions [14–25].
There are two stages in constructing a CSPBM: developing a
classiﬁcation system to provide standardized descriptions of
health states and generating a preference-based single index of
health state utility values (HSUVs) (QALY weights) for all health
states described by the classiﬁcation system [1]. We derived a
classiﬁcation system named the Multiple Sclerosis Impact Scale –
Eight Dimensions (MSIS-8D) [26] from the 29-item Multiple
Sclerosis Impact Scale (MSIS-29) [27,28]. Here, we report the
estimation of a preference-based index for the MSIS-8D. This
involved a valuation survey to elicit preferences for a sample of
MSIS-8D health states from a representative sample of the UK
general population, regression modeling to predict values for all
MSIS-8D health states, and validation of the resulting algorithm
in a large, representative data set of people with MS.The MSIS-8D Classiﬁcation System
The MSIS-29 is a validated and frequently used patient-reported
measure of HRQoL in MS. It consists of a physical subscale of 20
items and a psychological subscale of 9 items, each with four
response levels [28]. This range of items and levels would place
an unreasonable cognitive demand on respondents to the pref-
erence elicitation exercise required to estimate HSUVs. Therefore,
best practice methods were adopted to reduce the size of theinstrument while minimizing the loss of descriptive information
[1]. This involved mapping the items of the MSIS-29 to important
dimensions of HRQoL in MS, and undertaking Rasch and psycho-
metric analyses to select one item to represent each dimension,
using data from the South West Impact of Multiple Sclerosis
(SWIMS) longitudinal cohort study of people with MS [29]. The
resulting classiﬁcation system, the MSIS-8D, is presented in
Table 1. It comprises four items from the physical subscale of
the MSIS-29, which describe physical and social effects of MS, and
four items from the psychological subscale, which describe
emotional and other nonphysical effects, using the original
wording from the MSIS-29. The development of the MSIS-8D
has been reported elsewhere [26].Methods
Valuation
Here, we discuss our approach to some key aspects of valuation
survey design, including which health states to value, how to
elicit preferences, and whose values to elicit [30].
Health states
It is not possible to value all 65,536 MSIS-8D health states directly;
therefore, a sample was selected for the survey. Health state
samples are frequently selected using statistically efﬁcient
designs. For classiﬁcation systems constructed from unidimen-
sional scales, the increased likelihood of preference interactions
between attributes may result in the inclusion of implausible
health states [1], causing confusion for respondents and increas-
ing measurement error [31]. This can be addressed by basing the
selection of health states on the combination of item levels that
is most likely to occur at each level of condition severity. This
method, known as the Rasch vignette approach, is undertaken by
examining the Rasch threshold map [24]. The threshold between
adjacent item-response levels is deﬁned as the point on the
Rasch logit scale at which either response is equally probable.
Figure 1 shows the threshold map for the physical subscale of
the MSIS-8D, generated from the data set used to develop the
MSIS-8D classiﬁcation system. The x-axis shows the Rasch logit
scale, which represents increasing condition severity from left to
right. The threshold map shows the response level of each item
Fig. 1 – Threshold map for the MSIS-8D physical subscale. MS, multiple sclerosis; MSIS-8D, Multiple Sclerosis Impact Scale –
Eight Dimensions; SWIMS, South West Impact of Multiple Sclerosis.
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logit scale. For example, the most likely combination of item
levels for a respondent at logit 0 is level 2 on “physically
demanding tasks,” level 1 on “social and leisure limitations,”
level 1 on “stuck at home,” and level 1 on “time spent on daily
activities.”
This approach was modiﬁed for the MSIS-8D, which consists
of two unidimensional subscales. Combining each of the 13 sets
of item levels that appeared in the threshold map for the physical
subscale with all 13 sets from the threshold map for the
psychological subscale (13  13 sets) produced a sample of 169
health states, which included the pits state and the best health
state described by the MSIS-8D. On the basis of input from people
with MS, 12 health states that they considered implausible were
removed from the sample (details available in Appendix 1 in
Supplemental Material found at http://dx.doi.org/10.1016/j.jval.
2015.10.004). A further 12 states were added, as suggested by
Bagust [32], to inform future analysis of the impact of changes in
individual dimensions. These were all health states that differed
by one level from the pits state (e.g., 34444444) or by one level
from the best state (e.g., 21111111) and that did not appear in the
original sample of states. This provides additional information on
the impact of moving between health states that differ only by
one level on one dimension. The ﬁnal sample of 169 health states
is presented in Table 2.
On the basis of the time taken to complete health state
valuations during the prepilot testing, each respondent valued
six health states. Consistent with the approach taken in previous
studies [2,17,18,20,21,33,34], all respondents valued the pits state.
The remaining 168 states were assigned to ﬁve severity groups on
the basis of their total item-level scores. One health state was
selected at random without replacement from each severity
group to construct balanced sets of ﬁve health states. The survey
design comprised 34 sets of health states that were randomly
allocated to respondents [30].Preference elicitation
The Measurement and Valuation of Health variant of the time
trade-off (TTO) technique was used in accordance with the
methods used to obtain the UK index for the three-level EQ-5D
and the reference case recommended by the UK’s National
Institute of Health and Care Excellence [35,36]. Respondents are
asked to indicate whether they consider the target health state to
be better or worse than being dead by expressing a preference
between 10 years in the target state and immediate death. For
states considered better than dead, respondents choose between
Life B, in which they would spend 10 years in the target state
followed by death, and Life A, in which they would spend a
shorter period of time (x) in full health followed by death. Time x
is varied until the respondent is indifferent between the scenar-
ios (the indifference point), revealing the length of time (x) in full
health that the respondent considers equivalent to 10 years inthe target state. The value for the target state is calculated as x/
10. For states considered worse than dead, respondents choose
between (A) immediate death and (B) spending (10 – x) years in
the target state followed by x years in full health, after which they
would die. The value of x is varied until the indifference point is
reached. The value of the target state is calculated as –x/(10 – x)
[37].
An Internet-based survey was used to elicit preferences. Its
structure and content followed the Measurement and Valuation
of Health protocol [37], with some minor changes to the wording
of the original script to reﬂect the fact that the survey was being
completed online rather than face-to-face. Ethics approval was
obtained from the University of Exeter Medical School Research
Ethics Committee in June 2013. Online surveys have clear beneﬁts
in terms of cost and the time taken to collect data, eliminating
interviewer variation and transcription errors, and allowing
survey tools to be programmed to reduce the potential for
inconsistent responses [38]. The TTO technique, however, is not
commonly administered online and the complex nature of TTO
tasks may pose cognitive challenges for respondents in the
absence of an interviewer who can provide clariﬁcation [39]. It
has been argued that the advantages of online TTO surveys may
outweigh their disadvantages if they provide access to a geo-
graphically and demographically representative sample of the
target population, where this would otherwise not be possible, as
was the case for this study [40]. To ensure an acceptable level of
respondent burden, and to address any technical issues, the draft
survey was tested using think-aloud interviews with a conven-
ience sample (n ¼ 6), then amended and piloted online with 68
respondents. Empirical evidence suggests that naming the con-
dition can affect reported HSUVs [1]; therefore, respondents to
the main and pilot surveys were not informed that the health
states were caused by MS. This necessitated a change in the
wording of one MSIS-8D item: “How much has your MS limited
your ability to do physically demanding tasks?” The phrase “your
MS” was replaced by “your health.” Programming and hosting
were provided by Accent Marketing & Research Ltd.
The survey commenced with an introduction, demographic
and health-related questions, and three warm-up exercises:
completing the MSIS-8D questions themselves, ranking MSIS-8D
health states in order of preference, and undertaking a practice
TTO task. All respondents saw the same practice health state (see
Appendix 3 in Supplemental Material found at http://dx.doi.org/
10.1016/j.jval.2015.10.004). Respondents who did not prefer 10
years in full health to 10 years in the practice health state, or to
being dead, were screened out of the survey. Respondents then
provided preferences for six health states. The survey concluded
by asking respondents to rate how well they understood the TTO
task and how easy or difﬁcult they found it. To enhance the
quality of responses to online TTO questions, Norman et al. [41]
recommend excluding respondents engaging in strategic behav-
ior, such as completing the survey in less time than would be
required to give the TTO choices due consideration. In the
Table 2 – Mean observed health state utility values.
State Mean  SD Observations State Mean  SD Observations
Best state:
11111111 0.893  0.177 50 11114332 0.769  0.286 47
11111112 0.870  0.179 51 21113332 0.694  0.290 52
11111121 0.872  0.231 45 21123322 0.751  0.339 44
11111211 0.855  0.209 93 22123222 0.721  0.288 50
11112111 0.905  0.169 47 32122222 0.755  0.294 49
11121111 0.872  0.202 38 32222221 0.722  0.338 51
11211111 0.848  0.209 43 42222211 0.638  0.401 53
12111111 0.873  0.221 53 42232111 0.650  0.279 49
21111111 0.829  0.259 96 42331111 0.589  0.384 50
11112211 0.868  0.195 47 11114333 0.706  0.245 41
21112111 0.743  0.260 44 21114332 0.612  0.379 44
21121111 0.845  0.199 46 21123332 0.636  0.401 45
11112221 0.876  0.234 51 22123322 0.741  0.268 51
21112211 0.808  0.214 47 32123222 0.730  0.248 46
21122111 0.788  0.241 49 32222222 0.647  0.319 49
22121111 0.852  0.206 38 42222221 0.720  0.279 38
11112222 0.783  0.226 49 42232211 0.650  0.375 45
21112221 0.827  0.174 37 42332111 0.611  0.383 51
21122211 0.822  0.250 49 43331111 0.542  0.431 50
22122111 0.810  0.210 50 21114333 0.595  0.324 43
32121111 0.839  0.239 44 21124332 0.688  0.200 48
11113222 0.787  0.231 55 22123332 0.690  0.242 50
21112222 0.720  0.249 50 32123322 0.693  0.228 44
21122221 0.733  0.260 41 32223222 0.723  0.244 55
22122211 0.733  0.284 40 42222222 0.505  0.431 41
32122111 0.796  0.230 50 42232221 0.616  0.416 55
32221111 0.816  0.244 45 42332211 0.652  0.250 48
11113322 0.799  0.214 51 43332111 0.580  0.334 45
21113222 0.748  0.228 39 43341111 0.640  0.274 47
21122222 0.739  0.299 49 21124333 0.610  0.363 43
22122221 0.705  0.246 41 22124332 0.615  0.313 46
32122211 0.751  0.333 41 32123332 0.620  0.444 41
32222111 0.782  0.188 48 32223322 0.702  0.285 38
42221111 0.612  0.282 43 42223222 0.664  0.299 49
11113332 0.777  0.218 37 42232222 0.661  0.307 47
21113322 0.744  0.279 47 42332221 0.563  0.417 50
21123222 0.759  0.332 38 43332211 0.577  0.401 49
22122222 0.671  0.332 40 43342111 0.500  0.436 53
32122221 0.762  0.225 43 43441111 0.529  0.387 50
32222211 0.727  0.266 50 21124343 0.450  0.455 52
42222111 0.649  0.348 39 22124333 0.500  0.449 44
42231111 0.628  0.383 49 32124332 0.688  0.401 51
32223332 0.754  0.247 44 32224444 0.351  0.487 53
42223322 0.552  0.355 45 42224443 0.347  0.385 37
42233222 0.543  0.384 44 42234343 0.493  0.445 44
42332222 0.576  0.355 37 42334333 0.440  0.419 49
43332221 0.637  0.334 47 43334332 0.479  0.422 51
43342211 0.543  0.433 49 43343332 0.512  0.411 43
43442111 0.520  0.402 51 43443322 0.505  0.480 43
44441111 0.622  0.356 47 44443222 0.353  0.467 38
22124343 0.510  0.461 49 42224444 0.272  0.540 51
32124333 0.553  0.345 50 42234443 0.255  0.456 44
32224332 0.530  0.421 40 42334343 0.341  0.487 50
42223332 0.514  0.372 45 43334333 0.391  0.427 52
42233322 0.521  0.416 39 43344332 0.445  0.405 51
42333222 0.526  0.404 51 43443332 0.492  0.492 44
43332222 0.564  0.391 50 44443322 0.417  0.429 46
43342221 0.449  0.511 49 42234444 0.098  0.525 55
43442211 0.596  0.364 38 42334443 0.328  0.367 37
44442111 0.467  0.437 50 43334343 0.349  0.480 53
32124343 0.506  0.430 39 43344333 0.416  0.352 48
continued on next page
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Table 2 – continued.
State Mean  SD Observations State Mean  SD Observations
32224333 0.604  0.356 50 43444332 0.389  0.453 45
42224332 0.455  0.410 47 44443332 0.436  0.394 47
42233332 0.565  0.330 50 42334444 0.228  0.520 38
42333322 0.606  0.438 51 43334443 0.230  0.516 41
43333222 0.532  0.417 41 43344343 0.316  0.472 45
43342222 0.644  0.311 47 43444333 0.290  0.515 41
43442221 0.441  0.467 50 44444332 0.299  0.509 39
44442211 0.381  0.504 50 43334444 0.230  0.534 49
32224343 0.572  0.254 38 43344443 0.216  0.390 50
42224333 0.442  0.404 51 43444343 0.242  0.471 47
42234332 0.452  0.446 49 44444333 0.189  0.505 40
42333332 0.580  0.378 49 43344444 0.165  0.434 50
43333322 0.410  0.419 41 43444443 0.284  0.476 50
43343222 0.616  0.332 47 44444343 0.239  0.514 47
43442222 0.484  0.364 44 34444444 0.208  0.467 38
44442221 0.337  0.479 40 43444444 0.059  0.465 43
32224443 0.407  0.457 55 44344444 0.133  0.510 49
42224343 0.456  0.363 48 44434444 0.193  0.485 50
42234333 0.435  0.427 46 44443444 0.140  0.534 51
42334332 0.418  0.388 43 44444344 0.136  0.477 49
43333332 0.479  0.450 45 44444434 0.097  0.387 44
43343322 0.417  0.509 44 44444443 0.150  0.529 49
43443222 0.447  0.359 50 Pits state: 44444444 0.083  0.480 1576
44442222 0.380  0.478 52 All states 0.484  0.467 9456
Note. The list of health states is ordered according to the total sum of dimension levels (e.g., health state 11111111 has a sum of 8; health state
22222222 has a sum of 16).
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time limit, a judgment was made to exclude respondents who
spent less than 3 minutes completing the TTO questions for the
six health states from the survey results.
Further exclusion criteria were deﬁned a priori, on the basis of
similar previous studies [18–24,31,42,43], to exclude data in those
cases in which participants 1) valued the pits state at least as
highly as all other states, 2) gave the same value to all health
states (except those valuing all states as equivalent to full health),
3) gave all states a value less than or equal to 0, 4) gave the least
severe state a lower value than they did for all other states, and 5)
provided three or more inconsistent responses with a difference
of at least 0.1 in HSUV; that is, they valued a dominated health
state as better than a logically better alternative by the equivalent
of at least 1 year in the TTO exercise.Whose values
Health state values are typically sought from patients or the
general public. This is an important choice as patients’ values
have been found to differ signiﬁcantly from public values. In
jurisdictions in which health care is funded via general taxation,
public preferences are generally preferred, as reﬂected in the
guidance provided by decision-making bodies such as the
National Institute of Health and Care Excellence [36]. A repre-
sentative sample of the UK general population was sourced from
an existing Internet panel, using quotas for age, sex, and socio-
economic group. The panel was provided by Survey Sampling
International, whose selection procedures meet industry quality
assurance standards and incorporate a range of sources to
enhance responsiveness and reduce selection bias. Information
about the sample is provided in Appendix 2 in Supplemental
Material found at http://dx.doi.org/10.1016/j.jval.2015.10.004.Modeling to Obtain Health State Values
To estimate HSUVs for all health states described by the classi-
ﬁcation system, the values elicited from the survey were modeled
using multivariate regression. The standard form of the model is
[1] as follows:
hij¼ f ðβ0Xλ∂Þþεij ð1Þ
Where hij represents the TTO value; i ¼ 1, 2, n represents
individual health states; j ¼ 1, 2, m represents individual
respondents; f represents the functional form; X represents a
vector of dummy explanatory variables for each level λ of
dimension ∂ of the classiﬁcation system, where level λ ¼ 1 acts
as a baseline; and εij represents the error term.
We estimated individual-level and mean-level ordinary least
squares (OLS), ﬁxed effects or random effects (RE) models to
account for the clustering of data by respondent and RE Tobit
models to allow for the censoring of HSUV data between –0.975
and 1 [29]. Several versions of these models were explored. First,
the possibility of interactions between dimensions was inves-
tigated by creating a dummy variable, N4, to take a value of 1 if
any dimension is at its most severe level and 0 otherwise
[2,3,14,15,17]. Second, inconsistent coefﬁcients, where a less
severe item level resulted in a greater HRQoL decrement than
did a more severe item level, were merged and the analysis was
rerun to produce a consistent model. Finally, where one or more
coefﬁcients were nonsigniﬁcant at the 95% level, options for
merging the affected item levels were tested [23].
The standard practice of regressing dummy variables for
dimension levels onto observed HSUVs makes it difﬁcult to allow
for multiple interaction effects between dimensions. This would
require complex regression models, with several interaction
terms, and a larger number of health states would need to be
included in the valuation survey [16]. We explored an approach
devised to address this by providing a single independent
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[24]. This uses the mean Rasch logit value for each health state
(calculated by analyzing the SWIMS data set that was used to
derive the MSIS-8D classiﬁcation system [29]) as the independent
variable in the regression analysis.
We report model performance in terms of the proportion of
inconsistent coefﬁcients, the proportion of signiﬁcant coefﬁ-
cients, R2 and adjusted R2 statistics, and root mean squared
error [1]. Predictive ability was assessed using the mean abso-
lute error of predicted HSUVs and the number of health states
with absolute errors greater than 5% and 10% (equivalent to 6
months and 1 year in the TTO exercise, respectively). Selection
of the preferred model to generate the MSIS-8D index was based
on the proportion of signiﬁcant coefﬁcients and predictive
ability.
Validation
We investigated the extent of information lost in moving from
the MSIS-29 to the MSIS-8D, compared the sensitivity and
responsiveness of the MSIS-8D with two GPBMs (EQ-5D and SF-
6D), and assessed the likely impact of using the MSIS-8D rather
than a generic alternative on the results of cost-effectiveness
analyses [1]. Convergent and discriminative validity were
assessed using an extract from SWIMS [29,44]. The SWIMS project
is a longitudinal cohort study of people 18 years or older, with a
clinical diagnosis of MS or clinically isolated syndrome, living in
Devon and Cornwall. Participants are requested to complete
questionnaire packs on a 6-month basis, alternating between
two versions. The packs include various health status and HRQoL
measures, alongside questions on MS type, relapses and symp-
toms, medication, and use of health and social care services. The
study consistently achieves high return rates (c90%) and reten-
tion rates (8% of the participants were lost to follow-up in the ﬁrst
4 years) [29]. SWIMS data have been found to be comparable to
other UK-based samples of people with MS in terms of demo-
graphic characteristics such as age and sex [45–48] and in terms
of clinical characteristics such as relapse rates [49] and duration
of illness [50]. The extract included data on the MSIS-29 (version
2), the SF-36 (version 2), and the EQ-5D from 1403 respondents,
collected up to October 4, 2012. Observations per respondent
ranged from 1 to 19, with 11,196 data points overall. Adjustments
were made for autocorrelated data using panel data methods in
Stata 12.
Convergent validity between instruments was assessed using
Pearson correlation coefﬁcients [1]. Correlations can be assessed
as weak (o0.3), moderate (0.3–0.6), or strong (40.6) [51].
Discriminative validity was used as a measure of sensitivity.
This was assessed in terms of the ability to distinguish between
known subgroups of SWIMS respondents on the basis of their
self-reported HRQoL (MSIS-29 subscale scores), type of MS, and
whether or not they had experienced a relapse in the preceding 6
months, using one-way analyses of variance or independent t
tests, standardized effect sizes (the difference in mean scores
between two adjacent groups divided by the SD of scores for the
milder of the two groups), and absolute mean values [1]. Effect
sizes can be assessed as small (0.20–0.49), moderate (0.50–0.79), or
large (Z0.80) [52]. In this context, a higher effect size indicates
greater ability to distinguish between groups [1].
Although the SWIMS data are longitudinal, there was no
speciﬁc event that would be expected to result in a change in
HRQOL. As a result, responsiveness could not be assessed
directly. The ability of a measure to distinguish differences
between groups and to capture a wide range of health states
can provide an indication of its potential responsiveness [1].
Therefore, discriminative validity, ﬂoor effects, and ceiling effects
were used as proxy measures of responsiveness.Results
Valuation Survey
Data were obtained from 1702 respondents, representing 42.6% of
those who entered the survey Web site. Of these, 126 (7.4%) were
excluded from the analysis, mostly for valuing the pits state at
least as highly as all other states (n ¼ 106). Appendix 1 in
Supplemental Material provides the number of dropouts and
exclusions at each stage. Appendix 2 in Supplemental Material
presents the demographic characteristics of the ﬁnal sample (n ¼
1576) compared with the UK general population and respondents’
views of task comprehension and difﬁculty. Our sample had
slightly lower proportions of people who were older than 75
years, were in employment, or had no qualiﬁcations. More than
90% reported that they found the questions “very easy” or “easy”
to understand, around half said they found it easy or very easy to
choose between the options presented, and less than 5% found
this “very difﬁcult.”
Descriptive statistics for all directly valued health states are
presented in Table 2. Mean values ranged from 0.08 for the pits
state to 0.89 for the best state. The median number of observa-
tions per state was 47. The 9456 individual observations that
comprise the full valid data set are illustrated in Appendix
Figure 2 in Supplemental Material found at http://dx.doi.org/10.
1016/j.jval.2015.10.004, which shows the left skew and clustering
at 0 and 1 that are characteristic of TTO data [30]. Nearly one-
quarter of the observations (22.9%) were values of 0.9 or above.
These features were exacerbated because of the large proportion
of mild and severe states in the sample.
Modeling Health State Values
Table 3 summarizes the consistent individual and mean-level
OLS models; the original RE, main effects Tobit, and N4 Tobit
models; and the best-performing RE and Tobit models with
merged levels, on the basis of the proportion of signiﬁcant
coefﬁcients and predictive ability. Results for all other models
are available from the authors on request.
Only around one-third of the coefﬁcients for the OLS models
were signiﬁcant at the 95% level. Given that levels had already
been merged to address inconsistencies, no further merging was
explored for these models. The results of the Hausman test (χ2
value 17.50; 24 df; P ¼ 0.8264) informed the selection of a random
rather than a ﬁxed effects model [53]. The RE and Tobit models
produced relatively low proportions of signiﬁcant coefﬁcients;
therefore, various options for merging affected item levels were
explored (versions 2 and 3 presented in Table 3). The interaction
term (N4) was signiﬁcant only when added to the Tobit model.
OLS regression models were also generated using mean Rasch
logit values for the physical component and the psychological
component of each health state, comprising all possible combi-
nations of linear, quadratic, and cubic terms for the two logit
values [16].
Selection of the Preferred Model
The models based on Rasch logit values did not perform well,
compared with those based on the dimension levels of health
states (Table 3). The Rasch models (presented in Appendix 2 in
Supplemental Material) had the worst predictive ability, with
substantially higher mean absolute errors (0.051–0.059) and pro-
portions of health states with errors of more than 0.05 (43.8%–
47.9%). R2 and adjusted R2 values for these models were low
(o0.3) and root mean squared errors were high (40.39).
Overall, the RE models with merged levels performed best,
with higher proportions of signiﬁcant coefﬁcients than the OLS
Table 3 – Summary of models.
Dimension/ level and model performance Consistent OLS models Random effects models Tobit models Tobit with N4 term
Individual Mean level Original Version 2 Version 3 Original Version 2 Original Version 2
Physical
2. A little 0.073* 0.073* 0.052ǁ 0.052ǁ 0.053ǁ 0.104ǁ 0.105ǁ 0.102ǁ 0.115ǁ
3. Moderately 0.073ǁ 0.073ǁ 0.059‡ 0.060ǁ 0.060ǁ 0.115ǁ 0.118ǁ 0.112ǁ 0.124ǁ
4. Extremely 0.188ǁ 0.190ǁ 0.170ǁ 0.184ǁ 0.185ǁ 0.240ǁ 0.251ǁ 0.211ǁ 0.220ǁ
Social
2. A little 0.014 0.016 0.002 0§ 0§ 0.006 0§ 0.008 0.019*
3. Moderately 0.040 0.044† 0.012 0.028‡ 0.028‡ 0.018 0.012 0.021 0.019
4. Extremely 0.092‡ 0.103ǁ 0.063‡ 0.079ǁ 0.079ǁ 0.073‡ 0.068ǁ 0.077‡ 0.078ǁ
Mobility
2. A little 0.013 0.011 0.020 0.022* 0.022* 0.035† 0.035† 0.030 0.030*
3. Moderately 0.021 0.019 0.038 0.022 0.022 0.055‡ 0.066ǁ 0.050† 0.030
4. Extremely 0.062 0.061† 0.086ǁ 0.070ǁ 0.069ǁ 0.109ǁ 0.118ǁ 0.103ǁ 0.083ǁ
Daily activities
2. A little 0.007 0.007 0.023 0.024* 0.024* 0.028 0.031* 0.023 0§
3. Moderately 0.027 0.025 0.038 0.024 0.024 0.045 0.031† 0.038 0.035‡
4. Extremely 0.053 0.049 0.077ǁ 0.063ǁ 0.064ǁ 0.090ǁ 0.075ǁ 0.083‡ 0.094ǁ
Fatigue
2. A little 0.022* 0.024* 0.022 0.026* 0.026* 0.034‡ 0.036* 0.032† 0.035*
3. Moderately 0.022 0.024 0.025 0.026‡ 0.026‡ 0.039 0.036‡ 0.039 0.035‡
4. Extremely 0.089ǁ 0.094ǁ 0.077ǁ 0.087ǁ 0.088ǁ 0.094ǁ 0.090ǁ 0.076‡ 0.073ǁ
Emotion
2. A little 0.013 0.009 0.009 0§ 0§ 0.022 0.026* 0.022 0.026*
3. Moderately 0.033 0.030 0.037 0.050ǁ 0.041ǁ 0.059‡ 0.026† 0.060‡ 0.026†
4. Extremely 0.110ǁ 0.110ǁ 0.081ǁ 0.095ǁ 0.084ǁ 0.093ǁ 0.058‡ 0.099ǁ 0.067‡
Cognition
2. A little 0.023 0.025 0.011 0.032* 0.014* 0.008 0§ 0.007 0§
3. Moderately 0.033 0.033 0.032 0.032ǁ 0.014 0.030 0.050ǁ 0.028 0.046ǁ
4. Extremely 0.075‡ 0.072‡ 0.090ǁ 0.092ǁ 0.072ǁ 0.091ǁ 0.112ǁ 0.094ǁ 0.112ǁ
Depression
2. A little 0.018 0.020 0.026 0§ 0.029‡ 0.046‡ 0.064ǁ 0.044‡ 0.065ǁ
3. Moderately 0.073‡ 0.072ǁ 0.071ǁ 0.045ǁ 0.074ǁ 0.096ǁ 0.114ǁ 0.093ǁ 0.115ǁ
4. Extremely 0.145ǁ 0.148ǁ 0.158ǁ 0.131ǁ 0.161ǁ 0.187ǁ 0.206ǁ 0.187ǁ 0.206ǁ
N4 interaction term 0.047ǁ 0.048ǁ
Constant 0.893ǁ 0.895ǁ 0.883ǁ 0.881ǁ 0.882ǁ 1.061ǁ 1.062ǁ 1.062ǁ 1.064ǁ
Observations (groups) 9456 169 (1576) (1576) (1576) (1576) (1576) (1576) (1576)
Coefﬁcients po0.05 36.36% 36.36% 45.83% 88.24% 83.33% 62.50% 78.95% 54.17% 84.21%
Coefﬁcients po0.1 40.91% 45.45% 45.83% 88.24% 83.33% 70.83% 94.74% 62.50% 89.47%
Number of coefﬁcients 22 22 24 17 18 24 19 24 19
Mean absolute error 0.0398 0.0394 0.0411 0.0419 0.0414 0.0478 0.0486 0.0477 0.0487
Errors 4 0.1 8.28% 6.51% 5.33% 5.33% 6.51% 10.00% 8.88% 11.24% 9.47%
Errors 4 0.05 31.36% 30.18% 28.99% 30.77% 30.77% 42.50% 38.46% 41.42% 37.87%
R-squared 0.296 0.948
Adjusted R-squared 0.294 0.940
Root MSE 0.392 0.050
* levels 2 and 3 merged
† signiﬁcant at the p o 0.1 level
‡ signiﬁcant at the po0.05 level
§ levels 1 and 2 merged






























V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 1 0 2 5 – 1 0 3 61032models and the original RE model, and lower mean absolute
errors and number of errors than the Tobit models. RE version 2
generated slightly fewer errors (40.1), whereas RE version 3 had a
slightly lower mean absolute error and preserved a higher degree
of discrimination by retaining all four response levels within the
Depression dimension. On this basis, RE version 3 is the recom-
mended model for the estimation of a preference-based single
index for the MSIS-8D.
This model enables an HSUV to be calculated for any MSIS-8D
health state, by summing the constant and the coefﬁcient for
each item depending on its level. For example, the predicted
value for the practice MSIS-8D health state (3,2,3,3,3,2,3,1) is
calculated as follows:
ConstantþPhysical 3ð ÞþSocial 2ð ÞþMobility 3ð Þ
þDaily activities 3ð ÞþFatigue 3ð Þ
þEmotion 2ð ÞþCognition 3ð ÞþDepression 1ð Þ
¼0:882–0:060þ0–0:022–0:024–0:026þ0–0:014þ0¼0:736
The tariff ranges from 0.89 for the best MSIS-8D health state to
0.08 for the pits state, which is consistent with the range of
observed HSUVs.
Validation
Assessing the loss of information from the MSIS-29 to the MSIS-
8D
As reported in Table 4, relationships between the MSIS-8D and
the MSIS-29 subscales were very strong. There was very little
difference on ﬂoor and ceiling effects between the two measures.
Table 5 presents data describing the discriminative ability of
the MSIS-8D and the MSIS-29 subscales. Analysis of variance
F-test and t-test statistics provided very strong evidence that both
measures were capable of discriminating between known sub-
groups of people with MS (Po 0.001). Empirical data indicate that
people with MS report lower HSUVs when experiencing a relapse
[10] and that primary progressive MS has a greater impact on
HRQoL than does secondary progressive MS, which, in turn,
impacts more than does relapsing-remitting MS [11]. HSUVs
generated by both the MSIS-8D and the MSIS-29 subscale scoresTable 4 – Summary and correlations between measures.





Best score* 0.882 1
Worst score† 0.079 –0.594
Floor (%)‡ 1.22 0.08







EQ-5D-3L, three-level EuroQol ﬁve-dimensional questionnaire; MSIS-29, 2
state short form (derived from short form 36 health survey).
* Score (or value) corresponding to the best health state described by th
† Score (or value) corresponding to the worst health state described by t
‡ Floor effect ¼ percentage of respondents reporting the worst possible
§ Ceiling effect ¼ percentage of respondents reporting the best possiblereﬂected these expected differences. The differences in effect
sizes between the measures showed no overall pattern. Although
the effect sizes for the MSIS-8D between those with and without a
relapse in the previous 6 months and between those with
primary progressive MS (PPMS) and secondary progressive MS
were small (o0.49), this was also true of the physical MSIS-29
subscale for the former and of both subscales for the latter. The
moderate ability of the MSIS-8D to distinguish between people
with relapsing-remitting MS and PPMS compares to a small effect
size for the psychological subscale and a large effect size (40.8)
for the physical subscale. The MSIS-8D was equally able to
distinguish between benign and relapsing-remitting MS as the
physical subscale, and better able than the psychological sub-
scale of the MSIS-29.
Comparison between the MSIS-8D and GPBMs
As Table 4 illustrates, the GPBMs correlated less strongly than the
MSIS-8D did with the MSIS-29 subscales. The correlation between
the MSIS-8D and the MSIS-29 subscales was stronger than the
correlation between the MSIS-8D and the GPBMs.
The analysis of variance F-test and t-test statistics reported in
Table 5 indicated that all measures were capable of discriminat-
ing between subgroups (P o 0.001). In terms of effect sizes, the
MSIS-8D performed at least as well as the GPBMs. When the
grouped MSIS-29 subscale scores were used to deﬁne condition
severity, the MSIS-8D consistently outperformed the EQ-5D and
the SF-6D in terms of effect sizes. All three PBMs had similar,
small effect sizes (o0.49) for the grouping based on whether
respondents had experienced a relapse in the preceding 6
months. The MSIS-8D discriminated more effectively between
benign and relapsing-remitting MS than did the GPBMs, and all
three PBMs had similar effect sizes when distinguishing between
relapsing-remitting MS and PPMS (moderate) and between PPMS
and secondary progressive MS (small).
The GPBMs, however, tended to produce larger differences in
mean HSUVs between subgroups than did the MSIS-8D. Com-
pared with the EQ-5D, mean MSIS-8D values were lower for
subgroups expected to experience good HRQoL and higher for
















Table 5 – Comparing the discriminative validity of the MSIS-8D with MSIS-29 subscales and two generic preference-based measures.
Groupings based on MSIS-8D MSIS-29 Physical MSIS-29 Psychological
Mean  SD Obs ES Mean  SD Obs ES Mean  SD Obs ES
Relapse in the last 6 mo
Yes 0.579  0.192 1330 0.440 49.919  15.026 1343 0.339 20.779  6.690 1337 0.639
No 0.654  0.171 2304 44.567  15.785 2327 16.928  6.025 2325
t (Pr (|T| 4 |t|)) –12.22 (o0.001) 10.07 (o0.001) 17.88 (o0.001)
Type of MS
Benign 0.807  0.103 89 1.255 27.352  9.994 91 1.255 13.697  5.149 89 0.771
Relapsing-remitting 0.677  0.166 956 0.642 39.895  14.080 965 0.966 17.666  6.086 959 0.207
Primary progressive 0.570  0.183 416 0.072 53.501  13.874 423 0.153 18.924  6.470 420 0.129
Secondary progressive 0.557  0.175 403 55.622  13.493 407 19.758  6.551 405
F (prob 4 F) 98.26 (o0.001) 227.73 (o0.001) 28.12 (o0.001)
MSIS-8D EQ-5D SF-6D
Mean  SD Obs ES Mean  SD Obs ES Mean  SD Obs ES
MSIS-29 physical subscale
Score 20–35 0.794  0.073 1419 1.712 0.821  0.157 1401 1.330 0.753  0.109 257 1.321
Score 36–51 0.669  0.102 1688 1.581 0.612  0.201 1634 0.932 0.609  0.068 191 0.922
Score 52–67 0.507  0.138 1448 1.265 0.424  0.282 1359 0.946 0.546  0.075 135 0.836
Score 68–80 0.332  0.141 603 0.157  0.321 544 0.484  0.080 42
F (prob 4 F) 3050.70 (o0.001) 1320.82 (o0.001) 236.84 (o0.001)
MSIS-29 psychological subscale
Score 9–17 0.739  0.110 2481 1.504 0.701  0.254 2381 0.761 0.724  0.117 313 1.163
Score 18–26 0.574  0.131 1943 1.859 0.508  0.275 1846 0.827 0.588  0.087 231 0.832
Score 27–36 0.330  0.147 734 0.280  0.333 702 0.516  0.075 81
F (prob 4 F) 3286.37 (o0.001) 710.91 (o0.001) 195.45 (o0.001)
Relapse in the last 6 mo
Yes 0.579  0.192 1330 0.440 0.507  0.324 1288 0.349 0.589  0.111 1520 0.479
No 0.654  0.171 2304 0.612  0.303 2229 0.648  0.124 2640
t (Pr (|T| 4 |t|)) –12.22 (o0.001) –9.72 (o0.001) –15.44 (o0.001)
Type of MS
Benign 0.807  0.103 89 1.255 0.876  0.206 90 1.004 0.747  0.119 96 0.744
Relapsing-remitting 0.677  0.166 956 0.642 0.669  0.260 949 0.770 0.658  0.128 969 0.572
Primary progressive 0.570  0.183 416 0.072 0.469  0.324 399 0.072 0.585  0.110 433 0.157
Secondary progressive 0.557  0.175 403 0.445  0.313 390 0.568  0.098 436
F (prob 4 F) 98.26 (o0.001) 112.08 (o0.001) 111.54 (o0.001)
EQ-5D, EuroQol ﬁve-dimensional questionnaire; ES, effect size; MSIS-8D, Multiple Sclerosis Impact Scale – Eight Dimensions; MSIS-29, 29-item Multiple Sclerosis Impact Scale; Obs, observations;






























V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 1 0 2 5 – 1 0 3 61034values were higher among subgroups with good HRQoL and lower
for those with poor HRQoL.
As Table 4 shows, the MSIS-8D had the highest ﬂoor effect,
although this was very small. Around 5% of the respondents
reported the highest MSIS-8D value, compared with 9% on the
EQ-5D and less than 1% on the SF-6D.Discussion
We have estimated a preference-based single index for the MSIS-
8D classiﬁcation system for use as a CSPBM of health outcomes in
MS. The MSIS-8D enables HSUVs to be estimated from patient-
level MSIS-29 data. These HSUVs can be used across the full range
of condition severity in MS to assess HRQoL and to estimate
QALYs. The MSIS-29 is a well-validated and frequently used
patient-reported outcome measure for MS, developed with qual-
itative input from people with MS [27]. Deriving the classiﬁcation
system from the MSIS-29 presents potential advantages for this
CSPBM over generic alternatives.
Although concerns have been raised regarding comparability
between GPBMs and CSPBMs, these are arguably of less relevance
when the condition of interest is the primary determinant of
HRQoL, as is likely with severe conditions such as MS, and for
classiﬁcation systems with a broad range of dimensions, as is the
case with the MSIS-8D [1,54]. To aid comparability and policy
relevance, the valuation framework used here is consistent with
the methods recommended in a UK health policy setting [36]. To
further address concerns on comparability with GPBMs and to
enhance the policy relevance of the CSPBM, health states for the
MSIS-8D were not labeled as being for MS.
The Measurement and Valuation of Health protocol was
successfully administered using a Web-based survey. The survey
sample was broadly representative of the UK population in terms
of demographic characteristics, although Stein et al. [38] have
pointed out that members of online panels may differ from the
general public in less tangible ways. Concerns have also been
raised about the ability of respondents to comprehend complex
tasks such as the TTO in the absence of an interviewer [39].
Recent evaluations of online TTO using the EQ-5D have produced
mixed results. Some studies have found that Internet adminis-
tration produced different response patterns, increased variation
in HSUVs, clustering of responses (at –1, 0, and 1), and hence
reduced data quality than did the traditional interview-based
approach [41,55]. Conversely, Mulhern et al. [56] found no differ-
ence between valuation results obtained online or face-to-face.
Although acknowledging its potential disadvantages, Bansback
et al. [40] argue that online administration may be preferred in
those cases in which the resources available for the study would
restrict the ability of interviewers to access a geographically and
demographically representative sample of the target population.
The results reported here relating to self-reported task compre-
hension, and the nature of the preference data, suggest that the
complexity of the TTO technique need not prohibit Internet
administration, provided that instructions, warm-up tasks, and
testing procedures are adequate. The quality of the Internet panel
is an important factor in ensuring representativeness.
Results show that respondents did not consider the best MSIS-
8D health state to be equivalent to perfect health. This is a
common ﬁnding in studies of this type [14–20,23,24,42,43], and is
assumed to arise because of respondents taking other factors into
account, in addition to the information provided by the classiﬁca-
tion system [1]. To our knowledge, however, no research has been
reported to date that explores this. In the present study, we suggest
that one explanation could be the wording of the MSIS-8D items: it
is possible that respondents interpreted the phrase “not at all
bothered by” to mean that some impairment in health was present,but not sufﬁcient to “bother” them. Further qualitative research is
needed to understand this phenomenon. Descriptive statistics on
the values for the best MSIS-8D health state (n ¼ 50) show variation
in values, with 66% of the respondents valuing the state as
equivalent or close to full health (between 0.95 and 1.00).
Rasch methods were used to derive the MSIS-8D classiﬁcation
system and to select health states for valuation. Two previous
studies [16,24] have reported modeling HSUVs using Rasch logit
values, which were derived from the data set used to develop the
CSPBM classiﬁcation system. When we applied this approach to
the MSIS-8D, we found that it was able to predict HSUVs only for
health states that appeared in this data set. Mavranezouli et al.
[16] allocated HSUVs to the remaining health states by grouping
states according to their total item-level scores and applying the
same value to all health states within the same group. This was
based on the assumption that “health states with the same total
(ordinal) score correspond to the same Rasch logit value”16(p389);
however, this assumption did not hold in the MSIS-8D data set.
Given this issue, plus their relatively poor performance, we do
not recommend using Rasch-based models to predict HSUVs for
the MSIS-8D. There remain some unresolved issues in using this
promising new approach, which provide an important area for
future research.
The validation results provide promising support for the use
of the MSIS-8D as a CSPBM. Empirical evidence supports the
sensitivity [27,57–59] and responsiveness [59–65] of the MSIS-29.
Comparisons between the MSIS-8D and its parent measure
provide no indication that moving from the MSIS-29 to the
MSIS-8D resulted in a sufﬁcient loss of information to compro-
mise sensitivity or responsiveness.
The MSIS-8D correlated more strongly than the GPBMs with
MSIS-29 scores, indicating that it may better reﬂect HRQoL in MS.
In most cases, the MSIS-8D was better able to discriminate than
the EQ-5D or the SF-6D between groups, when this was assessed
using effect sizes. Brazier et al. [1] assert that larger effect sizes
could reduce uncertainty in the results of economic evaluations,
with positive implications for precision estimates and probabil-
istic sensitivity analyses, and suggest that the instrument may
require a smaller sample size to detect signiﬁcant differences.
Conversely, GPBMs identiﬁed larger differences in mean HSUVs
than did the MSIS-8D. This may support the argument that
GPBMs have more capacity to capture differences in HRQoL
caused by comorbidities or adverse effects. The difference in
the range of scores covered by these measures, however, makes
the interpretation of direct comparisons between mean values
problematic. A further ﬁnding from the results relating to abso-
lute mean values was the greater discriminatory ability of the
MSIS-8D compared with that of the EQ-5D at higher levels of
HRQoL, and its greater discriminatory ability than that of the SF-
6D at lower levels of HRQoL. This suggests that the MSIS-8D may
be more sensitive to differences across the full range of HRQoL
than is either of these frequently used PBMs. The expected
impact of this is that the MSIS-8D will generate higher HSUVs
for people whose HRQoL is severely compromised and lower
values for those with better HRQoL than would the EQ-5D, and
vice versa compared with the SF-6D.
The validation analysis was limited due to its reliance on a
single data set, which did not allow direct assessment of
responsiveness. Further validation, using other data sets,
would be beneﬁcial. The data on comparisons with the MSIS-
29 and the GPBMs, however, provide a basis for supporting the
use of the MSIS-8D in the assessment of HRQoL in MS. In the
ﬁrst instance, we suggest using the MSIS-8D alongside GPBMs
to further compare performance. Where studies have not
collected GPBM data, however, we suggest that the MSIS-8D
can provide a useful source of HSUVs if MSIS-29 data are
available.
V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 1 0 2 5 – 1 0 3 6 1035The MSIS-8D is a CSPBM that captures aspects of HRQoL
considered important by people with MS and is capable of
informing the assessment of health outcomes in MS. As with
all new measures, the MSIS-8D will beneﬁt from further valida-
tion; however, the evidence thus far suggests that it may offer
increased relevance and sensitivity over GPBMs.
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